Jonathan Stoever
Mount Sinai Hospital
4 Papers
Jonathan Stoever is an academic researcher from Mount Sinai Hospital. The author has contributed to research in topics: Antibody & Neutralization. The author has an hindex of 4, co-authored 4 publications.
Chat about Author
Papers
Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2.
Jéromine Klingler,Jéromine Klingler,Svenja Weiss,Svenja Weiss,Vincenza Itri,Xiaomei Liu,Xiaomei Liu,Kasopefoluwa Y. Oguntuyo,Christian S. Stevens,Satoshi Ikegame,Chuan-Tien Hung,Gospel Enyindah-Asonye,Fatima Amanat,Ian Baine,Suzanne Arinsburg,Juan C. Bandres,Erna Milunka Kojic,Jonathan Stoever,Denise Jurczyszak,Maria Bermudez-Gonzalez,Arthur Nádas,Sean T. H. Liu,Benhur Lee,Susan Zolla-Pazner,Catarina E. Hioe,Catarina E. Hioe +25 more
TL;DR: In this article, the authors studied spike and RBD-specific immunoglobulin isotypes in convalescent and acute plasma/serum samples using a multiplex bead assay.
A High-Throughput Assay for Circulating Antibodies Directed Against the S Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
Svenja Weiss,Jéromine Klingler,Catarina E. Hioe,Catarina E. Hioe,Fatima Amanat,Ian Baine,Suzanne Arinsburg,Erna Milunka Kojic,Jonathan Stoever,Sean T. H. Liu,Denise Jurczyszak,Maria Bermudez-Gonzalez,Viviana Simon,Florian Krammer,Susan Zolla-Pazner +14 more
TL;DR: A Luminex binding assay was developed and used to assess simultaneously the presence of coronavirus disease 2019 (COVID-19)–specific antibodies in human serum and plasma, and clear differentiation was achieved between specimens from infected and uninfected subjects, and a wide range of serum/plasma antibody levels was delineated in infected subjects.
31
A High Through-put Assay for Circulating Antibodies Directed against the S Protein of Severe Acute Respiratory Syndrome Corona virus 2.
Svenja Weiss,Jéromine Klingler,Catarina E. Hioe,Catarina E. Hioe,Fatima Amanat,Ian Baine,Erna Milunka Kojic,Jonathan Stoever,Sean T. H. Liu,Denise Jurczyszak,Maria Bermudez-Gonzalez,Viviana Simon,Florian Krammer,Susan Zolla-Pazner +13 more
TL;DR: Antibody assays of sera can identify individuals who are infected with SARS-CoV-2 and have seroconverted, as well as subjects who have been infected and recovered, and permits a high through-put of samples/day.
Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2.
Jéromine Klingler,Weiss S,Weiss S,Xiaomei Liu,Xiaomei Liu,Kasopefoluwa Y. Oguntuyo,Christian S. Stevens,Satoshi Ikegame,Chuan-Tien Hung,Gospel Enyindah-Asonye,Fatima Amanat,Ian Baine,Suzanne Arinsburg,Juan C. Bandres,Erna Milunka Kojic,Jonathan Stoever,Denise Jurczyszak,Maria Bermudez-Gonzalez,Simon,Arthur Nádas,Sean T. H. Liu,Benhur Lee,Florian Krammer,Susan Zolla-Pazner,Catarina E. Hioe,Catarina E. Hioe +25 more
TL;DR: Spike- and RBD-specific IgM, IgG1, and IgA1 antibodies were produced by all or nearly all subjects at varying levels and detected at 7-8 days post-disease onset, and neutralization titers correlated better with binding levels of IgM and Ig a1 than IgG.